China Aesthetic Injectable Market, 2026-2033

Name: China Aesthetic Injectable Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The aesthetic injectable market in China is expected to reach a projected revenue of US$ 5,811.2 million by 2033. A compound annual growth rate of 12.1% is expected of China aesthetic injectable market from 2026 to 2033.

China aesthetic injectable product outlook (Revenue, USD million, 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
  - Monophasic
  - Biphasic
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
China aesthetic injectable application outlook (Revenue, USD million, 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
China aesthetic injectable end use outlook (Revenue, USD million, 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others

China Aesthetic Injectable Market, 2026-2033

Sign up - it's easy, and free!